Improved AAV1 and AAV9 Vectors for Gene Delivery

被引：0
|
作者：
Balakrishnan, Balaji [1 ]
Krishnagopal, Akshaya [2 ]
Sen, Dwaipayan [1 ]
Srivastava, Alok [1 ,2 ]
Jayandharan, Giridhara R. [1 ,2 ]
机构：
[1] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India
[2] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
337
引用
收藏
页码：S130 / S131
页数：2
相关论文
共 50 条
  • [1] Broad Antibody Cross Reactions to Different AAV Serotypes in NHPs Following an Intravenous AAV9 or AAV1 Vector Delivery
    Pineda, Ricardo
    Meadows, Aaron
    Fu, Haiyan
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 106 - 106
  • [2] Characterization of HSV Derived AAV9 Vectors
    Pechan, Peter
    Golebiowski, Diane
    Seregin, Alexey
    Zapata, Nicole
    Levi, Elise
    Kitsos, Christine
    Lu, Robert
    Amorrortu, Alvaro
    Morris, Carl
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 347 - 347
  • [3] Improved heart specific gene transfer of AAV9 vectors with microRNA regulated transgene expression
    Geisler, Anja
    Jungmann, Andreas
    Vetter, Roland
    Muller, Oliver
    Fechner, Henry
    [J]. HUMAN GENE THERAPY, 2009, 20 (11) : 1381 - 1381
  • [4] AAV hybrid serotypes: Improved vectors for gene delivery
    Choi, VW
    McCarty, DM
    Samulski, RJ
    [J]. CURRENT GENE THERAPY, 2005, 5 (03) : 299 - 310
  • [5] Differential gene transfer to the choroid plexus after intrathecal delivery or in vitro exposure to AAV5, AAV8, and AAV9 viral vectors
    Churchill, C.
    Schuster, D.
    Schnell, S.
    Kitto, K.
    Peterson, C.
    Vulchanova, L.
    Fairbanks, C.
    [J]. JOURNAL OF PAIN, 2014, 15 (04): : S44 - S44
  • [6] Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
    Skorput, Alexander G. J.
    Gore, Reshma
    Schorn, Rachel
    Riedl, Maureen S.
    de Velasco, Ezequiel Marron Fernandez
    Hadlich, Bailey
    Kitto, Kelley F.
    Fairbanks, Carolyn A.
    Vulchanova, Lucy
    [J]. PLOS ONE, 2022, 17 (03):
  • [7] Optimization of elution conditions for immunoaffinity chromatography of AAV5 and AAV9 vectors
    Iurlova, E. V.
    Rebelin, M. S.
    Stukanev, V. K.
    Perepelkina, M. P.
    Gershovich, P. M.
    Madera, D. A.
    Karabelskii, A. V.
    Ivanov, R. A.
    Prokofyev, A. V.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A24 - A25
  • [8] Delivery of therapeutic AAV9 vectors via cisterna magna to treat neurological disorders
    Marchi, Paolo M.
    Marrone, Lara
    Azzouz, Mimoun
    [J]. TRENDS IN MOLECULAR MEDICINE, 2022, 28 (01) : 79 - 80
  • [9] Intrathecal delivery of AAV9 vectors to model and rescue a large animal model of SMA
    Duque, S.
    Porensky, P.
    William, D. A.
    Odermatt, P.
    Nlend, R. Nlend
    Bevan, A. K.
    Foust, K.
    Braun, L.
    Schmelzer, L.
    Schumperli, D.
    Kaspar, B. K.
    Burghes, A. H. M.
    [J]. NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 797 - 797
  • [10] Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
    Saraiva, Joana
    Nobre, Rui Jorge
    de Almeida, Luis Pereira
    [J]. JOURNAL OF CONTROLLED RELEASE, 2016, 241 : 94 - 109
12345